Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$0.93 - $1.38 $1,309 - $1,943
1,408 Added 95.91%
2,876 $3,000
Q3 2023

Oct 30, 2023

BUY
$0.93 - $1.38 $1,309 - $1,943
1,408 Added 95.91%
2,876 $4,000
Q2 2023

May 21, 2024

SELL
$1.11 - $2.05 $45 - $84
-41 Reduced 2.72%
1,468 $1,000
Q2 2023

Jul 27, 2023

SELL
$1.11 - $2.05 $45 - $84
-41 Reduced 2.72%
1,468 $2,000
Q1 2023

May 21, 2024

BUY
$1.63 - $2.02 $640 - $793
393 Added 35.22%
1,509 $2,000
Q1 2023

Apr 27, 2023

BUY
$1.63 - $2.02 $640 - $793
393 Added 35.22%
1,509 $3,000
Q4 2022

May 21, 2024

BUY
$1.68 - $3.7 $1,874 - $4,129
1,116 New
1,116 $2,000
Q4 2022

Jan 31, 2023

BUY
$1.68 - $3.7 $564 - $1,243
336 Added 43.08%
1,116 $2,000
Q3 2022

Oct 21, 2022

BUY
$3.43 - $4.01 $2,675 - $3,127
780 New
780 $3,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $31.6M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.